---
schema_version: "secwatch.filing_event.v1"
accession: "0001564590-22-001848"
form_type: "8-K"
ticker: "APVO"
cik: "0001671584"
company_name: "Aptevo Therapeutics Inc."
filed_at: "2022-01-21T23:59:59+00:00"
generated_at: "2026-06-27T16:32:47.508758+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Aptevo Chairman Fuad El-Hibri retires; John Niederhuber named Chairman effective April 1, 2022

## Summary
- Chairman Fuad El-Hibri retires effective April 1, 2022; no dispute with management or board.
- Dr. John Niederhuber, current Vice Chairman, appointed Chairman effective April 1, 2022.
- Board size reduced from 7 to 6 directors on April 1, 2022.
- El-Hibri to be available as advisor/consultant on terms to be agreed.

## SEC filing metadata
- accession: 0001564590-22-001848
- form_type: 8-K
- ticker: APVO
- cik: 0001671584
- company_name: Aptevo Therapeutics Inc.
- filed_at: 2022-01-21T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1671584/000156459022001848/0001564590-22-001848-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1671584/000156459022001848/apvo-8k_20220121.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001564590-22-001848
- JSON: https://secwatch.observer/filing/0001564590-22-001848.json
- Plain text: https://secwatch.observer/filing/0001564590-22-001848.txt

## Key facts
- Executive change
  Fuad El-Hibri departed as Chairman of the Board at Aptevo Therapeutics Inc..
  - Action: retired and resigned
  - Role: Chairman of the Board
  source text: On January 21, 2022, Fuad El-Hibri, Chairman of the Board of Directors (“Board”) of Aptevo Therapeutics Inc. (“Company”), notified the Company of his retirement and resignation as a director of the Company, effective April 1, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1671584/000156459022001848/0001564590-22-001848-index.htm
- Executive change
  John Niederhuber was appointed as Chairman of the Board at Aptevo Therapeutics Inc..
  - Action: appointed
  - Role: Chairman of the Board
  source text: On January 21, 2022, the Board appointed John Niederhuber, M.D. as Chairman of the Board effective April 1, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1671584/000156459022001848/0001564590-22-001848-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.